Bright Minds Biosciences
DRUG74.6305.02% ( +3.570 )
Bright Minds Biosciences (DRUG)
Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the Uni...
- Open
- 71.590
- High
- 75.500
- Low
- 71.445
- Prev. Close
- 71.060
- Volume
- 207.04K
- Turnover
- 15.36M
- Avg Price
- 74.203
- Bid/Ask Ratio
- --
- Amplitude
- 5.71%
- 52wk High
- 123.750
- Volume Ratio
- 0.94
- Turnover Ratio
- 3.13%
Bright Minds Biosciences Analyst Rating
View MoreForecast & Rating
Jun 4, 2026Price forecast
$168.56125.87%
Forecast & RatingStrong buy
7analysts
- Strong buy85.71%
- Buy14.29%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Market Beat · 1 day ago, 02:04 AM
ADAR1 Capital Management LLC Has $2.47 Million Stock Position in Bright Minds Biosciences Inc. $DRUG
- Simplywall · Jun 30 at 06:55 AM
We're Not Very Worried About Bright Minds Biosciences' (CSE:DRUG) Cash Burn Rate
- Tip Ranks · Jun 25 at 03:45 PM
H.C. Wainwright Keeps Their Buy Rating on Bright Minds Biosciences (DRUG)
- StockTitan · May 26 at 10:20 AM
Bright Minds Biosciences to Present at Jefferies Global Healthcare Conference | DRUG Stock News
- nasdaq · May 21 at 05:00 PM
Why a $5 Million New Position Signals Confidence in This Epilepsy Drug Pipeline
- ZeroHedge · Apr 22 at 07:37 AM
Psychedelic Stocks Just Went Mainstream
